BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹16 Cr | ₹13 Cr | ₹9.65 Cr | ₹6.17 Cr | ₹5.39 Cr |
What is the latest Total Non-Current Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹9.65 Cr |
| Mar2022 | ₹6.17 Cr |
| Mar2021 | ₹5.39 Cr |
How is Total Non-Current Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 28.69 | |
| Mar2024 | ₹13 Cr | 32.20 | |
| Mar2023 | ₹9.65 Cr | 56.49 | |
| Mar2022 | ₹6.17 Cr | 14.52 | |
| Mar2021 | ₹5.39 Cr | - | |
Compare Total Non-Current Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹482.3 Cr | -7.7% | 5.6% | 178.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,195.0 Cr | 0.9% | 5.6% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,823.0 Cr | 1.2% | 3.7% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,725.0 Cr | 4.4% | 10.3% | 42.1% | Stock Analytics | |
| CIPLA | ₹116,467.0 Cr | -1.7% | 3.1% | -4.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,987.0 Cr | 0.2% | 5.7% | 6% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -7.7% |
5.6% |
178.9% |
| SENSEX | -1% |
4.4% |
-8.3% |
You may also like the below Video Courses